Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Mather
M Chianelli

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|September 1, 1996
Radiolabelled cytokinesS J Mather, M Chianelli
Nuclear Medicine Communications|May 1, 1997
Radiopharmaceuticals for the study of inflammatory processes: a reviewM Chianelli, S J Mather, J Martin-Comin, et al.
Nuclear Medicine and Biology|August 1, 1997
The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseasesM Chianelli, A Signore, A R Fritzberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2008
99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility studyM Chianelli, S J Mather, A Grossman, et al.
Diabetes/Metabolism Research and Reviews|October 6, 2007
Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapyM Chianelli, M G Parisella, N Visalli, et al.
European Journal of Nuclear Medicine|August 22, 2000
Nuclear medicine in the developing countries: is there a role?M Chianelli
Nuclear Medicine Communications|March 1, 1992
Radiopharmaceutical licensingS J Mather
Nuclear Medicine Communications|March 1, 1993
Radiopharmaceutical licensing revisitedS J Mather
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1986
Radioiodinated monoclonal antibodies: a critical reviewS J Mather
Nuclear Medicine Communications|July 14, 2000
Radiolabelled peptides--promises and pitfallsS J Mather
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|September 1, 1996
Radiolabelled cytokinesS J Mather, M Chianelli
Nuclear Medicine Communications|May 1, 1997
Radiopharmaceuticals for the study of inflammatory processes: a reviewM Chianelli, S J Mather, J Martin-Comin, et al.
Nuclear Medicine and Biology|August 1, 1997
The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseasesM Chianelli, A Signore, A R Fritzberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2008
99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility studyM Chianelli, S J Mather, A Grossman, et al.
Diabetes/Metabolism Research and Reviews|October 6, 2007
Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapyM Chianelli, M G Parisella, N Visalli, et al.
European Journal of Nuclear Medicine|August 22, 2000
Nuclear medicine in the developing countries: is there a role?M Chianelli
Nuclear Medicine Communications|March 1, 1992
Radiopharmaceutical licensingS J Mather
Nuclear Medicine Communications|March 1, 1993
Radiopharmaceutical licensing revisitedS J Mather
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1986
Radioiodinated monoclonal antibodies: a critical reviewS J Mather
Nuclear Medicine Communications|July 14, 2000
Radiolabelled peptides--promises and pitfallsS J Mather
Pageof 14